Abstract
A new azalide antibiotic, azithromycin, was administered to 8 patients with infection, including 2 with acute pharyngitis, 1 with acute pharyngolaryngitis, 2 with acute bronchitis, 1 with mycoplasma pneumonia and 2 with chronic bronchitis. The result was evaluated as good in all 8 patients, while the bacteriological effect was eradicated in 3 patients “decreased” in 1 and “unknown” in 4. No adverse reactions or abnormal laboratory findings thought to be due to the administered drug was observed.
